Trial · NCT01914926
Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
NCT01914926, Phase 4, Completed, Antonios Likourezos; results first posted 2013-12-16
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter. Trials, record NCT01914926. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01914926
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
- NCT number
- NCT01914926
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 54 participants, actual
- Lead sponsor
- Antonios Likourezos
- Conditions
- Heart Rate and Rhythm Disorders
- Interventions
- Metoprolol, Diltiazem
- First posted
- 2013-08-02
- Last updated
- 2014-05-15
- Results first posted
- 2013-12-16
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent of Patients Reaching Target HR<100bpm Within 30 Minutes | 30 minutes | Percent of patient who reached a HR\<100bpm within 30 minutes from baseline. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent of Patients Reaching Target HR<100bpm Within 30 Minutes | 30 minutes | percentage of participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent of Patients Reaching Target HR<100bpm Within 30 Minutes | Metoprolol Study Group | 46.4 | percentage of participants | ||
| Percent of Patients Reaching Target HR<100bpm Within 30 Minutes | Diltiazem Study Group | 95.8 | percentage of participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Metoprolol Study Group | 29 | |
| Overall Study | STARTED | Diltiazem Study Group | 25 | |
| Overall Study | COMPLETED | Metoprolol Study Group | 28 | |
| Overall Study | COMPLETED | Diltiazem Study Group | 24 | |
| Overall Study | NOT COMPLETED | Metoprolol Study Group | 1 | |
| Overall Study | NOT COMPLETED | Diltiazem Study Group | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Metoprolol Study Group | ||
| Total, all-cause mortality | Diltiazem Study Group | ||
| Total, other adverse events | Metoprolol Study Group | 0 | 29 |
| Total, other adverse events | Diltiazem Study Group | 0 | 25 |
| Total, serious adverse events | Metoprolol Study Group | 0 | 29 |
| Total, serious adverse events | Diltiazem Study Group | 0 | 25 |
Source ClinicalTrials.gov
Papers13
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Metoprolol Study Group vs Diltiazem Study Group: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01914926
GET https://conductscience.org/api/trials/v1/NCT01914926/registered